Status:
RECRUITING
Auricular Vagal Nerve Stimulation for Spinal Fusion Surgery
Lead Sponsor:
Alexander T. Yahanda
Conditions:
Spinal Fusion
Hyperglycemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a randomized controlled trial that will evaluate the effect of non-invasive auricular vagal nerve stimulation on inflammatory markers, glycemic control, postoperative pain, and inflammat...
Detailed Description
Long-segment spinal fusions are effective interventions to relieve pain, neurological compromise, or disability related to a variety of causes of advanced spinal degeneration or spinal deformity. Desp...
Eligibility Criteria
Inclusion
- Long-segment spinal fusions (defined as constructs spanning at least L2-pelvis for thoracolumbar fusions or C2-T2 for cervical fusions)
- Ability to undergo a reliable neurologic examination and pain assessments
Exclusion
- Patients \<18 years of age
- Shorter-segment spinal fusions than those described above
- Undergoing current active cancer therapy
- Undergoing treatment with immunosuppressive drugs
- Additional spinal surgery within past 6 months
- Sustained bradycardia or presence of pacemaker
- History of substance abuse
Key Trial Info
Start Date :
October 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07218133
Start Date
October 8 2025
End Date
December 1 2026
Last Update
October 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110